This study investigated the role of protein ki nase C (PKC) in the pathogenesis of vasospasm after ex perimental subarachnoid hemorrhage (SAH). PKC acti vation by intracisternal injection of a phorbol ester [l2-O-tetradecanoylphorbol-13-acetate (TP)] induced dose dependent, slowly developing, severe contraction of the basilar artery. A single intracisternal injection of TP (5 x
10 -9 M in the CSF) induced sustained contraction lasting over 3 days, which almost paralleled the changes of mem brane-bound PKC activity in the basilar arterial wall. In a two-hemorrhage SAH model, membrane-bound PKC ac tivity in the basilar artery increased up to day 4 and re turned to the control level by day 14, whereas angio graphic contraction reached a maximum on day 7 and still
The exact etiological factors in the prolonged ce rebral vasospasm that occurs after subarachnoid hemorrhage (SAH) due to a ruptured intracranial aneurysm is still unknown. One hypothesis is that cerebral arterial narrowing is mainly produced by thickening of the vessel walls due to organic de rangement, since degenerative changes are known to occur in the endothelium and smooth muscle cells of the spastic arteries (Bevan and Bevan, 1988; Findlay et aI., 1989; Kim et aI., 1989; Sakaki et aI., 1989) . However, how and when these degenerative changes are induced following SAH remains un clear. Another opposing hypothesis is that pro longed contraction of the smooth muscle cells may persisted at a moderate level on day 14. Thus, there was a discrepancy between arterial PKC activity and arterial contraction. MUltiple intracisternal injections of TP pro duced 30-40% sustained contraction of the basilar artery lasting for more than 10 days along with sustained acti vation of PKC to levels compatible with that observed in the SAH model. However, TP injection caused consider ably milder histological changes in the basilar artery than those noted in the SAH model. We concluded that cere bral vasospasm after SAH cannot be explained solely on the basis of activation of the PKC pathway. Key Words: Cerebral vasospasm-Protein kinase C-Phorbol ester Sustained contraction-Myonecrosis. result in their degeneration, although no chemical substances responsible for such prolonged vasocon striction have been found in the CSF after SAH (Alksne and Greenhoot, 1974; Boullin et aI., 1978; Pennink et aI., 1972; Sasaki et aI., 1981; Shigeno, 1982) .
The protein kinase C (PKC) pathway may control the contraction and dilatation of the cerebral arter ies, because the activation of PKC with a phorbol ester elicits strong, dose-related, and slowly devel oping sustained contraction of these arteries (Ras mussen et aI., 1987; Sugawa et aI., 1991) . Matsui et ai. (1991) recently proposed that activation of the PKC pathway in vascular smooth muscle cells has a bearing on the pathogenesis of vasospasm, based upon the finding that severe angiographic narrowing of the basilar arteries in a beagle two-hemorrhage SAH model was significantly ameliorated on day 7 by topical PKC inhibitors. In addition, they showed that the content of 1,2-diacylglycerol, which is an intrinsic PKC activator, increased markedly in the basilar arteries in parallel with the progression of vasospasm.
To study the role of the PKC pathway in cerebral vasospasm after SAH, we examined the in vitro contractile response of canine basilar arteries fol lowing activation of the PKC pathway with a phor bol ester, and also made an in vivo PKC activator model by single or multiple intracisternal injections of the phorbol ester into the canine basilar arteries. Then we compared the arterial contraction induced by the PKC activator and by two-hemorrhage SAH with regard to the PKC activity and the morpholog ical features.
MATERIALS AND METHODS
Adult mongrel dogs were anesthetized with an intrave nous injection of sodium thiamylal (10 mg/kg) and intu bated following the intramuscular injection of ketamine hydrochloride (5 mg/kg) and atropine sulfate (0.5 mg). The right femoral artery was catheterized for continuous recording of systemic blood pressure and pulse rate. Ar terial blood gases and body temperature were maintained within the physiological range using artificial ventilation and a heating blanket.
One hundred thirty-six mongrel dogs weighing 7 to 15 kg were divided into four groups for the following pur pos � s: isometric tension measurement in vitro (n = 12); angiography (n = 41) and PKC activity measurement (n = 51) following single and multiple intracisternal injec tions of phorbol ester in vivo; angiography (n = 30) and PKC activity measurement (n = 35) following SAH; and morphological study in both models (n = 23).
Isometric tension measurement
Anesthetized normal animals were killed by exsangui nation via a femoral venous catheter. The basilar arteries were immediately removed and placed into Krebs Henseleit (K-H) solution [composition in mM: NaCl, 118; KCl, 5.32; NaH2P04, 1.54; MgS04 (7H20), 1.19; NaHC03, 24.9; CaC12, 2.53; dextrose, 5.6; ethylenedi amine tetraacetic acid (2 Na) (EDTA(2Na», 0.01] main tained at 37°C and pH 7.4, and gassed with a mixture of 95% 02/5% CO2, The arteries were dissected into 2 x 20 mm spiral strips with the aid of an operating microscope using Speden's procedure (Speden, 1960) . Each strip was fixed vertically between hooks in a 20-ml organ bath con taining K-H solution. The hook anchoring the upper end of the strip was connected to the lever of a force displacement transducer (Nihon Kohden FD-61lT, To kyo, Japan). Isometric tension was measured by a strain gauge transducer attached to a preamplifier (Nihon Kohden AP-601G) and recorded on a potentiometric chart recorder (Pantos U-638). The resting tension was set at 1.0 g, which proved to be optimal for inducing maximum contraction, and the preparation was allowed to equilibrate for 60-90 min, during which time the bath ing solution was renewed every 15-20 min. After the equilibration, contractile responses of the strips to 50 mM KCl were repeated two or three times until the responses were reproducible. To obtain dose-response relation ships, KCl, 5-hydroxytryptamine (5-HT), and a phorbol ester (12-0-tetradecanoylphorbol-13-acetate, TP) were added directly to the bathing medium in cumulative con- 1993 centrations without renewal of the solution as soon as the maximum response to the preceding concentration had been obtained. Contractile responses to each agent were expressed as a percentage of the 50-mM KCl-induced contraction. TP and 5-HT were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). TP was dissolved in 99.0% dimethyl sulfoxide and diluted with distilled wa ter before use.
Angiography of the basilar artery
Angiography was performed serially before and after the intracisternal injection of autologous arterial blood and TP as described later. Four milliliters of Iopamidol (Iopamiron; Japan Schering Co., Tokyo, Japan) was in jected via a femoral catheter which was placed in the left vertebral artery. All angiograms were taken under a fixed magnification. The inside diameter of the basilar artery was mea .
sured with a microcomputer image analyzer, and contractIOn was assessed by determining the mean per centage of the control diameter at lO points previously selected at regular distances along the vessel. The changes in the basilar artery were observed for 7 to 21 days.
To produce a two-hemorrhage SAH model, the cisterna magna was punctured with a 22-gauge needle and 0.8 mIl kg of autologous arterial blood obtained from the femoral artery was slowly injected under sterile conditions with out removal of CSF. The dogs were tilted head down at 15° for 30 min to allow the injected blood to bathe the basal cisterns. This procedure was repeated twice at an interval of 48 h, namely, firstly on day 1 and secondly on day 3 (Varsos et ai., 1983) .
To assess the changes in basilar arterial diameter after a single intracisternal injection of TP, the cisterna magna was punctured with a 22-gauge needle, and 1 ml of TP (0.12 ng/kg-24 fJ-g/kg) dissolved in 1% dimethyl sulfoxide was slowly injected under sterile conditions after removal of the same volume (1 ml) of CSF. This concentration of dimethyl sulfoxide had no effect on the canine basilar artery. The final concentration of TP in the CSF was determined to be 1 x lO-10 to 2 X 10-5 M, assuming that canine CSF volume is 2.0 mllkg (Oppelt et al., 1964; Roth man et al., 1961; Zoghbi et al., 1985) .
To confirm that the contraction of the basilar artery following the intracisternal injection of TP was induced by the activation of PKC, a PKC inhibitor (staurosporine) was injected intracisternally 30 min before the intracister nal injection of TP. Then angiograms were obtained con secutively for the next 4 h. The concentration of stauro sporine in the CSF was estimated to be 5 x lO-7 M and that of TP was 1 x lO-8 M. Staurosporine was obtained from Sigma Chemical Co.
To investigate the enhancing effect of multiple injec tions of TP, additional intracisternal injections of TP at 6.0 ng/kg (5 x 10-9 M in the CSF) were given on days 3 and 7.
Measurement of PKC activity in the basilar artery
After perfusing the brain transcardially with 1.0 L of saline (4°C) at a constant pressure of 120 mm Hg during exsanguination, the basilar arteries were rapidly removed and homogenized in ice-cold 50 mM Tris-HCl buffer (pH 7.5) containing 5 mM EDTA(2Na), 10 mM ethylene gly col-bis(J3-aminoethylether)N,N,N' ,N' -tetraacetic acid, 0.3% (w/v) J3-mercaptoethanol, 10 mM benzamidine, and 50 IJ-g/ml phenylmethylsulfonyl fluoride. The total protein content of the homogenate was measured using a Bio-Rad protein assay kit (Bio-Rad, Richmond, VA, U. S.A. ). The homogenate was then centrifuged at 100,000 g for 60 min and the supernatant containing the cytosolic PKC frac tion was removed. The pellet was resuspended in the buffer described above containing 1. 0% Triton X-loo and shaken at 4°C for 60 min. The solution thus obtained was diluted with the buffer to a final concentration of 0. 5% Triton X-loo and centrifuged again at 100,000 g for an other 60 min. The supernatant was used as the membrane fraction ofPKC. PKC activity was measured using a PKC enzyme assay system (Amersham, Buckingham, U. K. ). The activity was measured as the 32p radioactivity incor porated into the specific peptide for PKC and was ex pressed in pmol min � 1 mg protein � 1.
PKC activity was measured in the two-hemorrhage SAH model and in the single and mUltiple TP injection (5 x 1O�9 M in the CSF) models.
Morphological study
The experimental animals that received multiple intra cisternal injections of TP or two-hemorrhage SAH were killed on day 10, after transcardial perfusion fixation with 1. 0 L of saline and 1. 0 L of 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7. 4) at a constant pressure of 120 mm Hg during exsanguination via a femoral venous cath eter. The basilar arteries were postfixed with 2% OS04 for 2 h at 4°C, stained with uranyl acetate, and dehydrated through a graded series of ethanols. The specimens were embedded in Quetol 812 (Nishin E.M. Co. , Tokyo, Ja pan), sectioned with an ultramicrotome, stained again with uranyl acetate and lead citrate, and observed under a Hitachi H-800 transmission electron microscope (To kyo, Japan).
Statistical analysis
All data are presented as the mean ± SD. Statistical analysis was performed using Scheffe's test to compare variables among the experimental groups.
RESULTS
Isometric tension of the basilar arteries developed by TP, KCl, and 5-HT Maximum contractile response to 50-mM KCI was 1.57 ± 0.33 g. TP induced dose-dependent con traction of the canine basilar artery which devel oped slowly but progressively (Fig. 1) . Contraction started within 5-10 min, reached a maximum at 60 min, and persisted for at least 8 h. The potency of the contraction induced by TP was much stronger than that caused by KCI (a depolarizing agent) or that induced via the Ca 2 + -calmodulin pathway ini tiated by 5-HT. Furthermore, TP-induced contrac tion persisted considerably longer, over 6 h, than that induced by the other agents. We also confirmed that TP-induced contraction remained unchanged even after the solution had been washed out for several hours. In the two-hemorrhage SAH model, basilar arte rial contraction reached a maximum on day 7 and still persisted at a moderate level on days 14 and 21 (Fig. 2) . TP (at CSF concentrations above 1 x 10-8 M) induced slowly developing but severe contraction that reached a maximum 5 h after injection, when the basilar arteries could no longer be demonstrated by angiography (Fig. 3A ). All the dogs in this state died of sudden cardiac arrest a few minutes later.
At CSF concentrations below 5 x 10-9 M, TP produced maximal contraction between 4 h and 3 days after injection (basilar arterial diameter was Changes in the diameter of the canine basilar artery after SAH (the control diameter was taken as 100%). Each value represents the mean ± SO. There was a significant difference from the control on days 1-21 after SAH. reduced by 30--40% from the control at 5 x 10-9 M, 20-30% at 1 x 10-9 M, and 10% at 1 x 10-10 M). The contraction gradually subsided from 3 days af ter TP injection and was almost undetectable on day 7 (Fig. 3B ). Vital signs did not change in these an imals. The contraction induced by TP was com pletely inhibited by preinjection of staurosporine. MUltiple intracisternal injections of TP produced basilar arterial contraction of more than 30% that lasted for 10 days. The severity and duration of con traction in this model were comparable to the find ings in the two-hemorrhage SAH model (Fig. 4) .
Changes in PKC activity in the basilar artery
The cytosolic and membrane-bound PKC activi ties in the normal canine basilar artery were 931 ± 49 and 119 ± 20 pmol min -1 mg protein -1, respec tively. In the SAH model, the membrane-bound PKC activity increased to 342 ± 70 pmol min -1 mg protein -1 on day 4 and then returned gradually to the control level by day 14. The cytosolic PKC ac tivity decreased significantly from 4 h to day 14 after SAH, and the total PKC activity (cytosol plus membrane) decreased significantly on day 2 and from days 7 to 14 (Fig. 5) . Comparison with the course of angiographic vasospasm showed that the SO. There were significant differences from the control on days 1-10. Multiple injections of TP could produce more than 30% narrowing of the basilar artery lasting for 10 days.
increase of membrane-bound PKC activity pre ceded maximal vasoconstriction by several days, and that PKC activity was normalized while basilar arterial contraction still persisted at 14 days after SAH.
In the single TP injection model (5 x 10-9 M in the CSF), the membrane-bound PKC activity in creased significantly up to 4 h (421 ± 124 pmol min -1 mg protein -1) and then decreased gradually to reach the control level on day 7 (Fig. 6A ). Basilar arterial contraction almost paralleled the increase in membrane-bound PKC activity.
In the mUltiple TP injection model (5 x 10-9 M, x 3), membrane-bound PKC activity increased again on days 3 and 7 at 4 h after the second and third injections, and there were three activations of membrane-bound PKC which were 1.2 times higher than the peak observed in the SAH model (Fig. 6B ).
Morphological study
In SAH dogs killed on day 10, the basilar arteries showed marked degenerative changes. The vascu lar endothelial cells showed deformed nuclei, cyto plasmic vacuoles, and loss of tight junctions (Fig.  7a) , whereas the smooth muscle cells featured the loss of nuclei and organelles, the appearance of vac uoles and dense bodies, and fragmentation of myo filaments, suggesting the occurrence of myonecro sis (Fig. 7c) . The stroma was filled with collagen fibers, dense particles, and thicker basement mem brane-like substances. On the other hand, the mul tiple TP injection animals killed on day 10 showed marked intimal corrugation (Fig. 7b) and deformity of the smooth muscle cells of the basilar artery (Fig.  7d ), but no evidence of myonecrosis. Time after initial TP injection DISCUSSION Biochemical modulation of the molecular interac tion between actin and myosin has been elucidated in regulation of the contraction and relaxation of smooth muscle cells. Two mechanisms are cur rently proposed for this process. One is the cal cium-calmodulin pathway, in which the phosphor ylation of myosin light chain creates a cross-bridge between actin and myosin filaments, a process me diated by the activation of myosin light chain kinase following the formation of a Ca 2 + -calmodulin com plex (Adelstein et aI., 1980; Aksoy et aI., 1982 Aksoy et aI., , 1983 Murphy et aI., 1983) . Contraction produced through this pathway is generally transient; it is also suggested that additional phosphorylation of myo sin filaments may change this transient contraction to persistent contraction with little consumption of energy (Rembold and Murphy, 1986; Summerville FIG. 7 . Transmission electron micrographs of canine basilar arteries on day 10 after SAH (a,c) and after multiple injections of TP at a CSF concentration of 5 x 10-9 M (b,d) . In the SAH model, there were cytoplasmic vacuoles and loss of tight junctions in the endothelium (a; x4,700; bar, 5 fLm), as well as disappearance of nuclei and organelles in the smooth muscle cells suggesting myonecrosis (c; x3,200; bar, 5 fLm) . In the multiple TP injection model, the tight junctions were maintained in the endothelium despite marked intimal corrugation (b; x4,700; bar, 5 fLm). In addition, there were no findings suggesting myonecrosis in the smooth muscle layer (d; x3,200; bar, 5 fLm). and Hartshorne, 1986). However, an earlier study of ours showed that the Ca 2 + -calmodulin pathway probably does not participate in arterial narrowing during the delayed vasospasm following SAH be cause the calmodulin concentration was decreased significantly in the contracted arteries in a two hemorrhage canine model (Sakaki et al., 1989) .
Another pathway may operate via PKC, which regulates numerous intracellular functions (Nishi zuka, 1986b is the spatial translocation of the enzyme. PKC is mainly located in the cytosol under resting condi tions, and is rapidly translocated to the membrane after hormonal stimulation (Nishizuka, 1984) . For this reason, the level of membrane-bound PKC ac tivity is considered to represent the active enzyme. PKC participation in smooth muscle contraction has been demonstrated by the in vitro finding that exposure of intact arterial strips to a phorbol ester induces rapid and sustained translocation of this en-zyme from the cytosol to the membrane in smooth muscle cells, a process which is accompanied by slowly developing, sustained contraction of the ar tery for several hours without activation of myosin light chain kinase (Haller et aI., 1990; Griendling et aI., 1986; Khalil and van Breemen, 1987; Rasmus sen et aI., 1984) . In the present study, we also dem onstrated that sustained and dose-dependent con traction of the basilar artery was produced by a phorbol ester (TP) (Fig. 1) , a finding which agrees with Rasmussen's data obtained in rabbit ear arter ies. The contraction produced by PKC activation is suggestive of a role for this enzyme in vasospasm after SAH.
We studied the relationship between PKC activa tion in the basilar artery and basilar arterial contrac tion induced by intracisternal TP. Following a sin gle intracisternal injection of TP, all dogs in which the CSF concentration of TP was over 1 x 10 -8 M developed sudden cardiac arrest immediately after the disappearance of the basilar artery on angio grams (Fig. 3A) . This event was interpreted as rep resenting ischemic damage to the brain stem due to excessive vasoconstriction. Nishizuka et al. (1986a) pointed out that using TP at doses above 1 x 10-8 M is of little value, because the PKC reaction induced by such high concentrations is too strong for comparison with the maximum response produced by intrinsic PKC activators. Therefore, we selected a CSF concentration of 5 x 10-9 M for TP as an appropriate level for examining the role of PKC in vasospasm after SAH. At this concentra tion, TP induced basilar arterial contraction of 30-40% that lasted for 3 days. It activated PKC in the basilar arterial wall up to day 3, with the peak ac tivity occurring at 4 h after injection (Figs. 3B and 6A). Comparison with the angiograms showed that the arteries developed contraction in proportion to the increase in membrane-bound PKC activity, and then dilated again almost in parallel with its decline. That is, there was a correlation between membrane bound PKC activity and basilar arterial contraction.
PKC activation has not been assessed in the ce rebral arteries after actual SAH, so we measured the PKC activity in a two-hemorrhage SAH model. We found a discrepancy in the relationship between membrane-bound PKC activity and basilar arterial contraction, because maximal contraction occurred on day 7 and moderate contraction still persisted on day 21, whereas membrane-bound PKC activity gradually declined from before day 7 and returned to baseline before day 14 (Figs. 2 and 5) .
In order to develop a model which reproduced arterial contraction persisting for more than 10 days induced by PKC activation, we injected 6.0 ng/kg TP intracisternally at 3-day intervals (5 x 10-9 M in the CSF). Multiple injections of TP produced over 30% contraction of the basilar artery that lasted for more than 10 days and was quite comparable to the SAH model ( Figs. 2 and 4) . Moreover, this proce dure stimulated PKC activity in the basilar arterial wall more than in the two-hemorrhage model, be cause each injection of TP activated PKC 1.2 times higher than the peak observed in the SAH model ( Figs. 5 and 6B ). Nevertheless, much less severe morphological changes were observed in the basilar artery in the TP model when compared with the SAH model (Fig. 7) . These results indicated that activation of the PKC pathway alone cannot induce all the pathological changes of vasospasm following SAH, especially myonecrosis of the cerebral arter ies.
